,
doi.org/10.1046/j.1365-2141.2000.02402.x, hdl.handle.net/1765/62302
British Journal of Haematology
Department of Hematology

de Vetten, M.P, Jansen, J.H, van der Reijden, B.A, Berger, M.S, Zijlmans, J.M, & Löwenberg, B. (2000). Molecular remission of Philadelphia/bcr-abl-positive acute myeloid leukaemia after treatment with anti-CD33 calicheamicin conjugate (gemtuzumab ozogamicin, CMA-676). British Journal of Haematology, 111(1), 277–279. doi:10.1046/j.1365-2141.2000.02402.x